Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
University of South Florida
ClinicalTrials.gov Identifier:
NCT00579280
First received: December 18, 2007
Last updated: January 13, 2011
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2010
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)